Pfizer’s drug succeeds in late-stage blood cancer trial
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Pfizer said on Tuesday a combination treatment using its drug, Adcetris, met the main goal of a late-stage study of extending survival in patients with a type of blood cancer.
:max_bytes(150000):strip_icc():format(jpeg)/savingsvscdnews-98809008e8464a429fd41d4c5a32dd38.jpg "What Metrics Can Be Used to Evaluate Companies in the Financial Services Sector?")
:max_bytes(150000):strip_icc():format(jpeg)/FPM-Best-Personal-Loans-Methodology-Recirc-468fcab5bfa84ae485bd56843cf5c0eb.png "How We Review and Rate Personal Loan Lenders")
